Policy Implications of an Approximate Linear Infection Model for SARS-CoV-2

Competing Interest Statement

Both authors received funding as Consultants for Delaware North, a company that may be affected by the research reported in the paper.

Funding Statement

Both authors received funding as Consultants for Delaware North, a company that may be affected by the research reported in the paper. McCarthy received funding from the National Institutes of Health, Grant R01 AG052550-01A1, and the National Science Foundation, Grant DMS 1565243

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

None needed

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes